Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

4.5
(373)
Write Review
More
$ 21.50
Add to Cart
In stock
Description

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus

Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis - Jiabin Wang, Shi Yan, Xiaoli Chen, Aowen Wang, Zhibin Han, Binchao Liu, Hong Shen, 2022

Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models? - Computational and Structural Biotechnology Journal

Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses - ScienceDirect

PDF) Survival analysis in breast cancer using proteomic data from four independent datasets

Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints

Protein disulfide isomerase A3 activity promotes extracellular accumulation of proteins relevant to basal breast cancer outcomes in human MDA-MB-A231 breast cancer cells

Cancers, Free Full-Text

Applying a GAN-based classifier to improve transcriptome-based prognostication in breast cancer, by Abish Pius, Computational Biology Papers

Diagnostics, Free Full-Text